Jayne David R.W.
SEC CIK 1838242 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | Dir | 56.5K | — | $126.7K | 6 | 2022-05-18 | 2024-11-21 |
Most active insiders at AUPH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TANG KEVIN | Dir | $25.14M | — |
| 2 | Robertson Stephen P. | EVP, GC | — | $546.4K |
| 3 | Cole Ryan | COO | — | — |
| 4 | Keenan Greg | SVP, Chief Medical Off | — | — |
| 5 | Hearne Michael S | CFO | — | — |
| 6 | Miller Joseph M | CFO | — | — |
| 7 | Donley Matthew Maxwell | COO | — | — |
| 8 | Bailey Jeffrey Allen | Dir | — | — |
| 9 | Johnson Craig A | Dir | — | — |
| 10 | Greenleaf Peter | CEO, Dir | — | — |
Jayne David R.W. made no open-market trades at AUPH in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-25 | 2024-11-21 | AUPH | Aurinia Pharmaceuticals Inc. | Jayne David R.W. | Dir | A - Grant | $0.00 | +12.1K | 56.5K | +27% | $0 |
| 2024-05-22 | 2024-05-21 | AUPH | Aurinia Pharmaceuticals Inc. | Jayne David R.W. | Dir | S - Sale | $5.74 | -4,946 | 44.4K | -10% | -$28.4K | |
| D | 2023-05-23 | 2023-05-18 | AUPH | Aurinia Pharmaceuticals Inc. | Jayne David R.W. | Dir | M - OptEx | — | +8,733 | 48.7K | +22% | — |
| D | 2023-05-23 | 2023-05-23 | AUPH | Aurinia Pharmaceuticals Inc. | Jayne David R.W. | Dir | S - Sale+OE | $11.26 | -8,733 | 49.3K | -15% | -$98.3K |
| D | 2023-05-23 | 2023-05-19 | AUPH | Aurinia Pharmaceuticals Inc. | Jayne David R.W. | Dir | A - Grant | $0.00 | +9,310 | 58.0K | +19% | $0 |
| DA | 2022-07-11 | 2022-05-18 | AUPH | Aurinia Pharmaceuticals Inc. | Jayne David R.W. | Dir | M - OptEx | $3.62 | +10.0K | 40.0K | +33% | +$36.2K |
Purchase Sale Sale after option exercise All abbreviations